(Q33260497)

24 July 2017

title

Alternative technologies in cervical cancer screening: a randomised evaluation trial (English)

1 reference

24 July 2017

main subject

cervix uterine cancer

1 reference

Ahti Anttila

1

1 reference

24 July 2017

Matti Hakama

series ordinal

2

1 reference

24 July 2017

Laura Kotaniemi-Talonen

series ordinal

3

1 reference

24 July 2017

Pekka Nieminen

series ordinal

4

1 reference

24 July 2017

language of work or name

English

0 references

publication date

16 October 2006

1 reference

24 July 2017

1 reference

24 July 2017

volume

6

1 reference

24 July 2017

page(s)

252

1 reference

Creative Commons Attribution 2.0 Generic

24 July 2017

copyright license

start time

16 October 2006

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1621071

Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1621071

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1621071

Cervical cancer screening programmes and policies in 18 European countries

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1621071

The cervical cancer epidemic that screening has prevented in the UK.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1621071

Management of women who test positive for high-risk types of human papillomavirus: the HART study

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1621071

Papillomaviruses and cancer: from basic studies to clinical application

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1621071

Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1621071

Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1621071

A systematic review of the role of human papillomavirus testing within a cervical screening programme

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1621071

Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1621071

International incidence rates of invasive cervical cancer before cytological screening

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1621071

Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1621071

Sensitivity of the AutoPap 300 QC System for cervical cytologic abnormalities. Biopsy data confirmation

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1621071

The Papanicolaou test for cervical cancer detection. A triumph and a tragedy

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1621071

Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1621071

Consequences of neural network technology for cervical screening: increase in diagnostic consistency and positive scores.

14 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-6-252

A randomised public-health trial on automation-assisted screening for cervical cancer in Finland: performance with 470,000 invitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-6-252

DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-6-252

Comparison of human papillomavirus messenger RNA and DNA detection: a cross-sectional study of 4,136 women >30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-6-252

A controlled trial of a human papillomavirus type 16 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-6-252

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-6-252

Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: results of the first year.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-6-252

Colorectal cancer screening in Finland: details of the national screening programme implemented in Autumn 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-6-252

Accelerated decline in cervical cancer mortality in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-6-252

Trends in Cervical Squamous Cell Carcinoma Incidence in 13 European Countries: Changing Risk and the Effects of Screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-6-252

Randomized evaluation trial on automation-assisted screening for cervical cancer: results after 777,000 invitations

21 January 2018

1 reference

12 December 2020

Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer

1 reference

12 December 2020

Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes

1 reference

12 December 2020

PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears

1 reference

12 December 2020

Colposcopy for the diagnosis of squamous intraepithelial lesions: A meta-analysis

1 reference

12 December 2020

Risk of cervical cancer after a negative Pap smear

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2458-6-252

1 reference

Dimensions Publication ID

24 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2458-6-252

9 September 2019

1 reference

24 July 2017

1 reference